Effect of normal and immune sera on Haemophilus ducreyi 35000HP and its isogenic MOMP and LOS mutants

Microbial Pathogenesis

Volumn 26, Issue 2, 1999, Pages 93-102

  Hiltke, Thomas J ^a   Bauer, Margaret E ^a   Klesney Tait, Julia ^b   Hansen, Eric J ^b   Munson Jr , Robert S ^c,d   Spinola, Stanley M ^a  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Bactericidal activity; Chancroid; Haemophilus ducreyi

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; COMPLEMENT; HYPERIMMUNE GLOBULIN; LIPOPROTEIN; OUTER MEMBRANE PROTEIN; PEPTIDOGLYCAN; RABBIT ANTISERUM;

ANTIBODY TITER; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; CLINICAL TRIAL; COLONY FORMING UNIT; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE INSERTION SEQUENCE; HAEMOPHILUS DUCREYI; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SERUM; ULCUS MOLLE;

ANIMALIA; BACTERIA (MICROORGANISMS); HAEMOPHILUS; HAEMOPHILUS DUCREYI 35000HP; NEGIBACTERIA; ORYCTOLAGUS CUNICULUS;

EID: 0033083061     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1998.0250     Document Type: Article

References (43)

1. Trees DL, Morse SA. Chancroid and Haemophilus ducreyi: An update. Clin Microbiol Rev 1995; 8: 357-75.
2. Brunham RC, Ronald AR. Epidemiology of sexually transmitted diseases in developing countries. In: Wasserheit JN, Aral SO, Holmes KK, Hitchcock PJ, Eds. Research Issues in Human Behavior and Sexually Transmitted Diseases in the AIDS Era. Washington DC: American Society for Microbiology, 1995; 61-80.
3. Jessamine PG, Ronald AR. Chancroid and the role of genital ulcer disease in the spread of human retrovirus. Med Clin N Am 1990; 74: 1417-31.
4. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually trasmitted diseases. Sex Transm Dis 1992; 19: 61-77.
5. Moran E, Brandt B, Zollinger W. Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity. Infect Immun 1994; 62: 5290-5.
6. Rice PA. Molecular basis for serum resistance in Neisseria gonorrhoeae. Clin Microbiol Rev 1989; 2 (Suppl): 112-17.
7. Van Der Voort ER, van der Ley P, Van Der Biezen J, et al. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine. Infect Immun 1999; 64: 2745-51.
8. Taylor PW. Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microbiol Rev 1993; 47: 46-83.
9. Lagergard T, Frisk A, Purven M, Nilsson LA. Serum bactericidal acativity and phagocytosis in host defence against Haemophilus ducreyi. Microb Pathog 1995; 18: 37-51.
10. Odumeru JA, Wiseman GM, Ronald AR. Virulence factors of Haemophilus ducreyi. Infect Immun 1984; 43: 607-11.
11. Odumeru JA, Wiseman GM, Ronald AR. Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum. Infect Immun 1985; 50: 495-9.
12. Spinola SM, Orazi A, Arno JN et al. Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. J Infect Dis 1996; 173: 394-402.
13. Spinola SM, Wild LM, Apicella MA, Gaspari AA, Campagnari AA. Experimental human infection with Haemophilus ducreyi. J Infect Dis 1994; 169: 1146-50.
14. Frisk A, Ahmed HJ, Van Dyck E, Lagargård T. Antibodies specific to surface antigens are not effective in complement-mediated hilling of Haemophilus ducreyi. Microb Pathog 1998; 25: 67-75.
15. Klesney-Tait J, Hiltke TJ, MacIver I, Spinola SM, Radolf JD, Hansen EJ. The major outer membrane protein of Haemophilus ducreyi consists of two OmpA homologs. J Bact 1997; 179: 1764-73.
16. Fernandez RC, Weiss AA. Cloning and sequencing of a Bordetella pertussis serum resistance locus. Infect Immun 1994; 62: 4727-38.
17. Kasper DL, Rice PA, McCormack WM. Bactericidal antibody in genital infection due to Neisseria gonorrhoeae. J Infect Dis 1977; 135: 243-51.
18. Zollinger WD, Mandrell RE. Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide. Infect Immun 1983; 40: 257-64.
19. Morse SA. Chancroid and Haemophilus ducreyi. Clin Microbiol Rev 1989; 2: 137-57.
20. Albritton WL, Maclean IW, Slaney LA, Ronald AR, Deneer HG. Plasmid-mediated tetracycline resistance in Haemophilus ducreyi. Antimicrob Agents Chemother 1984; 25: 187-90.
21. Hansen EJ, Latimer JL, Thomas SE, Helminen M, Albritton WL, Radolf JD. Use of electroporation to construct isogenic mutants of Haemophilus ducreyi. J Bact 1992; 174: 5442-9.
22. Purcell BK, Richardson JA, Radolf JD, Hansen EJ. A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi. J Infect Dis 1991; 164: 359-67.
23. Abeck DA, Johnson P, Wall RA, Shah L. Haemophilus ducreyi produces rough lipopolysaccharide. FEMS Microbiol Lett 1987; 42: 159-61.
24. Hollyer TT, DeGagne PA, Alfa MJ. Characterization of the cytophathic effect of Haemophilus ducreyi. Sex Transm Dis 1994; 21: 247-57.
25. Lagergård TM, Purven M, Frisk A. Evidence of Haemophilus ducreyi adherence to and cytotoxin destruction of human epithelial cells. Microb Pathog 1993; 14: 417-31.
26. Odumeru JA, Wiseman GM, Ronald AR. Relationship between lipopolysaccharide composition and virulence Haemophilus ducreyi. J Med Microbiol 1987; 23: 155-62.
27. Palmer KL, Goldman WE, Munson RS Jr. An isogenic hemolysin-deficient mutant of Haemophilus ducreyi lacks the ability to produce cytopathic effects on human foreskin fibroblasts. Mol Microbiol 1996; 21: 13-19.
28. Green BA, Quinn-Dey T, Zlotnick GW. Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influenzae type b. Infect Immun 1987; 55: 2878-83.
29. Murphy TF, Bartos LC, Rice PA, Nelson MB, Dudas KC, Apicella MA. Identification of a 16,600-dalton outer membrane protein on nontypeable Haemophilus influenzae as a target for human serum bactericidal antibody. J Clin Invest 1986; 78: 1020-7.
30. Hansen EJ, Lumbley SR, Richardson JA, et al. Induction of protective immunity to Haemophilus ducreyi in the temperature-dependent rabbit model of experimental chancroid. J Immunol 1994; 152: 184-92.
31. Melaugh W, Phillips NJ, Campagnari AA, Tullius MV, Gibson BW. Structure of the major oligosaccharide from the lipooligosaccharide of Haemophilus ducreyi 35000 and evidence for additional glycoforms. Biochemistry 1994; 33: 13070-8.
32. Melaugh W, Campagnari AA, Gibson BW. The lipooligosaccharides of Haemophilus ducreyi are highly sialylated. J Bact 1996; 178: 564-70.
33. Mandrell RE, Lesse AJ, Sugai JV, et al. In Vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J Exp Med 1990; 171: 1649-64.
34. Parsons NJ, Patel PV, Tan EL, et al. Cytidine 5′-mono-phospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum. Microb Pathog 1988; 5: 303-9.
35. Rice PA, Vayo HE, Tam MR, Blake MS. Immunoglobulin G antibodies directed against Protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum. J Exp Med 1986; 164: 1735-48.
36. Weiser JN, Gotschlich EC. Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Excherichia coli K-1. Infect Immun 1991; 59: 2252-8.
37. Spinola SM, Griffiths GE, Bogdan JA, Menegus MA. Characterization of an 18,000 molecular-weight outer membrane protein of Haemophilus ducreyi that contains a conserved surface-exposed epitope. Infect Immun 1992; 60: 385-91.
38. Gibson BW, Campagnari AA, Melaugh W, et al. Characterization of a transposon Tn916- Generated mutant of Haemophilus ducreyi 35000 defective in lipooligosaccharide biosynthesis. J Bact 1997; 179: 5062-71.
39. Spinola SM, Hiltke TJ, Fortney K, Shanks KL. The conserved 18,000-molecular-weight outer membrane protein of Haemophilus ducreyi has homology to PAL. Infect Immun 1996; 64: 1950-5.
40. Hiltke TJ, Campagnari AA, Spinola SM. Characterization of a novel lipoprotein expressed by Haemophilus ducreyi. Infect Immun 1996; 64: 5047-52.
41. Spinola SM, Griffiths GE, Shanks KL, Blake MS. The major outer membrane protein of Haemophilus ducreyi is a member of the OmpA family of proteins. Infect Immun 1993; 61: 1346-51.
42. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
43. Munson RS Jr, Granoff DM. Purification and partial characterization of outer membrane proteins P5 and P6 from Haemophilus influenzae type b. Infect Immun 1985; 49: 544-9.